Stocktoria
Tonix Pharmaceuticals Holding Corp. TNXP
Tonix Pharmaceuticals Holding Corp. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.1M | $10.1M | $7.8M | — | — | — | — | — | — | — |
| R&D expense | $44.5M | $40.0M | $86.7M | $81.9M | $68.8M | $36.2M | $18.2M | $17.6M | $13.3M | $28.5M |
| SG&A expense | $87.7M | $40.1M | $34.8M | $30.2M | — | — | — | — | — | — |
| Operating income | -$125.7M | -$136.7M | -$118.4M | -$112.1M | -$92.3M | -$50.5M | -$28.8M | -$26.3M | -$21.3M | -$39.0M |
| Net income | -$124.0M | -$130.0M | -$116.7M | -$110.2M | -$92.3M | -$50.5M | -$28.6M | -$26.1M | -$21.1M | -$38.8M |
| EPS (diluted) | $-14.57 | $-176.60 | $-14720.25 | $-20.01 | $-8.10 | — | — | — | — | — |
| Operating cash flow | -$99.8M | -$60.9M | -$102.0M | -$98.1M | -$75.6M | -$48.6M | -$26.7M | -$24.0M | -$19.1M | -$37.3M |
| Free cash flow | -$103.2M | -$61.0M | -$109.9M | -$146.2M | -$110.9M | -$57.1M | -$26.7M | -$24.0M | -$19.1M | -$37.4M |
| Cash & equivalents | $207.6M | $98.8M | $24.9M | $120.2M | $178.7M | $77.1M | $11.2M | $25.0M | $25.5M | $18.9M |
| Inventory | — | $8.4M | $13.6M | — | — | — | — | — | — | — |
| Total assets | $277.2M | $162.9M | $154.5M | $225.7M | $240.9M | $98.2M | $14.6M | $26.3M | $26.8M | $27.5M |
| Total liabilities | $32.0M | $23.3M | $48.9M | $18.5M | $22.2M | $10.5M | $5.1M | $2.7M | $2.1M | $2.1M |
| Shareholders' equity | $245.2M | $139.6M | $105.5M | $207.2M | $218.7M | $87.6M | $9.4M | $23.7M | $24.6M | $25.4M |
Growth · year-over-year · Revenue CAGR 29.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +29.8% | +29.9% | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.